Sleep apnea and glucose metabolism: The new challenge

Sleep Medicine

Volumn 7, Issue 7, 2006, Pages 538-540

  Viot Blanc, Véronique ^a   Lévy, Patrick ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE EXACERBATION; EDITORIAL; FOLLOW UP; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; NONHUMAN; OBESITY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP PATTERN; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 33749451804     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.05.013     Document Type: Editorial

References (32)

1. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet 365 (2005) 1046-1053
2. Arzt M., Young T., Finn L., et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 200505-200702OC
3. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
4. Gami A.S., and Somers V.K. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 25 (2004) 709-711
5. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
6. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
7. Sundstrom J., Riserus U., Byberg L., et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Br Med J 332 (2006) 878-882
8. Strohl K.P., Novak R.D., Singer W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 17 (1994) 614-618
9. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
10. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
11. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 (2002) 677-682
12. Stoohs R.A., Facchini F., and Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154 (1996) 170-174
13. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 (2004) 521-530
14. Reichmuth K.J., Austin D., Skatrud J.B., et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172 (2005) 1590-1595
15. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26 (2003) 702-709
16. Punjabi N.M., Ahmed M.M., Polotsky V.Y., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136 (2003) 167-178
17. Harsch I.A., Schahin S.P., Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
18. Czupryniak L., Loba J., Pawlowski M., et al. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep 28 (2005) 601-603
19. Saini J., Krieger J., Brandenberger G., et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 (1993) 375-381
20. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 (1995) 172-179
21. Babu A.R., Herdegen J., Fogelfeld L., et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165 (2005) 447-452
22. Hassaballa H.A., Tulaimat A., Herdegen J.J., et al. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9 (2005) 176-180
23. Lindberg E, Berne C, Elmasry A, et al. CPAP treatment of a population-based sample - what are the benefits and the treatment compliance? Sleep Med doi:10.1016/j.sleep.2005.12.010.
24. Brooks B., Cistulli P.A., Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79 (1994) 1681-1685
25. Smurra M., Philip P., Taillard J., et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2 (2001) 207-213
26. Sandhu M.S., Heald A.H., Gibson J.M., et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359 (2002) 1740-1745
27. Juul A., Scheike T., Davidsen M., et al. Low serum insulin-like growth factor is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106 (2002) 939-944
28. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
29. Spiegel K., Leproult R., L'Hermite-Baleriaux M., et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 89 (2004) 5762-5771
30. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 (2005) 863-867
31. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552 (2003) 253-264
32. Turek F.W., Joshu C., Kohsaka A., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308 (2005) 1043-1045